• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

Pharma & HealthcareGlobal Human Rabies Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2414271
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 123 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Rabies vaccine is a vaccine used to prevent rabies.They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite.The immunity that develops is long lasting after a full course.

Scope of the Report:

This report focuses on the Human Rabies Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Global human rabies vaccines market is expected to witness robust growth over the forecast period. Increasing global incidences of mortality due to rabies, growing issue of stray dogs in countries with low economic development, rising number of pets, lack of pet management services, low immunization rates in pets, and rising friendliness with pets are drivers estimated to boost growth of human rabies vaccine market.

The worldwide market for Human Rabies Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Sanofi Pasteur,Inc.

Novartis Vaccines and Diagnostics Ltd.

Cadila Pharmaceuticals Ltd.

GlaxoSmithKline Biologicals

Merck&Co Inc.

Wyeth pharmaceuticals

Berna Biotech Ltd.

Medimmune LLC

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Vero Cell Rabies Vaccine

BHK

Chick Embryo Cell Rabies Vaccine

Others

Market Segment by Applications, can be divided into

Pre-Exposure Prophylaxis

Post-Exposure Prophylaxis

There are 15 Chapters to deeply display the global Human Rabies Vaccines market.

Chapter 1, to describe Human Rabies Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Human Rabies Vaccines, with sales, revenue, and price of Human Rabies Vaccines, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Rabies Vaccines, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Human Rabies Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Human Rabies Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

1 Market Overview

1.1 Human Rabies Vaccines Introduction

1.2 Market Analysis by Type

1.2.1 Vero Cell Rabies Vaccine

1.2.2 BHK

1.2.3 Chick Embryo Cell Rabies Vaccine

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Pre-Exposure Prophylaxis

1.3.2 Post-Exposure Prophylaxis

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Sanofi Pasteur,Inc.

2.1.1 Business Overview

2.1.2 Human Rabies Vaccines Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sanofi Pasteur,Inc. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novartis Vaccines and Diagnostics Ltd.

2.2.1 Business Overview

2.2.2 Human Rabies Vaccines Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Cadila Pharmaceuticals Ltd.

2.3.1 Business Overview

2.3.2 Human Rabies Vaccines Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 GlaxoSmithKline Biologicals

2.4.1 Business Overview

2.4.2 Human Rabies Vaccines Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Merck&Co Inc.

2.5.1 Business Overview

2.5.2 Human Rabies Vaccines Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Merck&Co Inc. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Wyeth pharmaceuticals

2.6.1 Business Overview

2.6.2 Human Rabies Vaccines Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Berna Biotech Ltd.

2.7.1 Business Overview

2.7.2 Human Rabies Vaccines Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Berna Biotech Ltd. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Medimmune LLC

2.8.1 Business Overview

2.8.2 Human Rabies Vaccines Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Medimmune LLC Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Human Rabies Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Human Rabies Vaccines Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Human Rabies Vaccines Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Human Rabies Vaccines Manufacturer Market Share in 2017

3.3.2 Top 6 Human Rabies Vaccines Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Human Rabies Vaccines Market Analysis by Regions

4.1 Global Human Rabies Vaccines Sales, Revenue and Market Share by Regions

4.1.1 Global Human Rabies Vaccines Sales and Market Share by Regions (2013-2018)

4.1.2 Global Human Rabies Vaccines Revenue and Market Share by Regions (2013-2018)

4.2 North America Human Rabies Vaccines Sales and Growth Rate (2013-2018)

4.3 Europe Human Rabies Vaccines Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Human Rabies Vaccines Sales and Growth Rate (2013-2018)

4.5 South America Human Rabies Vaccines Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Human Rabies Vaccines Sales and Growth Rate (2013-2018)

5 North America Human Rabies Vaccines by Countries

5.1 North America Human Rabies Vaccines Sales, Revenue and Market Share by Countries

5.1.1 North America Human Rabies Vaccines Sales and Market Share by Countries (2013-2018)

5.1.2 North America Human Rabies Vaccines Revenue and Market Share by Countries (2013-2018)

5.2 United States Human Rabies Vaccines Sales and Growth Rate (2013-2018)

5.3 Canada Human Rabies Vaccines Sales and Growth Rate (2013-2018)

5.4 Mexico Human Rabies Vaccines Sales and Growth Rate (2013-2018)

6 Europe Human Rabies Vaccines by Countries

6.1 Europe Human Rabies Vaccines Sales, Revenue and Market Share by Countries

6.1.1 Europe Human Rabies Vaccines Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Human Rabies Vaccines Revenue and Market Share by Countries (2013-2018)

6.2 Germany Human Rabies Vaccines Sales and Growth Rate (2013-2018)

6.3 UK Human Rabies Vaccines Sales and Growth Rate (2013-2018)

6.4 France Human Rabies Vaccines Sales and Growth Rate (2013-2018)

6.5 Russia Human Rabies Vaccines Sales and Growth Rate (2013-2018)

6.6 Italy Human Rabies Vaccines Sales and Growth Rate (2013-2018)

7 Asia-Pacific Human Rabies Vaccines by Countries

7.1 Asia-Pacific Human Rabies Vaccines Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Human Rabies Vaccines Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Human Rabies Vaccines Revenue and Market Share by Countries (2013-2018)

7.2 China Human Rabies Vaccines Sales and Growth Rate (2013-2018)

7.3 Japan Human Rabies Vaccines Sales and Growth Rate (2013-2018)

7.4 Korea Human Rabies Vaccines Sales and Growth Rate (2013-2018)

7.5 India Human Rabies Vaccines Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Human Rabies Vaccines Sales and Growth Rate (2013-2018)

8 South America Human Rabies Vaccines by Countries

8.1 South America Human Rabies Vaccines Sales, Revenue and Market Share by Countries

8.1.1 South America Human Rabies Vaccines Sales and Market Share by Countries (2013-2018)

8.1.2 South America Human Rabies Vaccines Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Human Rabies Vaccines Sales and Growth Rate (2013-2018)

8.3 Argentina Human Rabies Vaccines Sales and Growth Rate (2013-2018)

8.4 Colombia Human Rabies Vaccines Sales and Growth Rate (2013-2018)

9 Middle East and Africa Human Rabies Vaccines by Countries

9.1 Middle East and Africa Human Rabies Vaccines Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Human Rabies Vaccines Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Human Rabies Vaccines Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Human Rabies Vaccines Sales and Growth Rate (2013-2018)

9.3 UAE Human Rabies Vaccines Sales and Growth Rate (2013-2018)

9.4 Egypt Human Rabies Vaccines Sales and Growth Rate (2013-2018)

9.5 Nigeria Human Rabies Vaccines Sales and Growth Rate (2013-2018)

9.6 South Africa Human Rabies Vaccines Sales and Growth Rate (2013-2018)

10 Global Human Rabies Vaccines Market Segment by Type

10.1 Global Human Rabies Vaccines Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Human Rabies Vaccines Sales and Market Share by Type (2013-2018)

10.1.2 Global Human Rabies Vaccines Revenue and Market Share by Type (2013-2018)

10.2 Vero Cell Rabies Vaccine Sales Growth and Price

10.2.1 Global Vero Cell Rabies Vaccine Sales Growth (2013-2018)

10.2.2 Global Vero Cell Rabies Vaccine Price (2013-2018)

10.3 BHK Sales Growth and Price

10.3.1 Global BHK Sales Growth (2013-2018)

10.3.2 Global BHK Price (2013-2018)

10.4 Chick Embryo Cell Rabies Vaccine Sales Growth and Price

10.4.1 Global Chick Embryo Cell Rabies Vaccine Sales Growth (2013-2018)

10.4.2 Global Chick Embryo Cell Rabies Vaccine Price (2013-2018)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2013-2018)

10.5.2 Global Others Price (2013-2018)

11 Global Human Rabies Vaccines Market Segment by Application

11.1 Global Human Rabies Vaccines Sales Market Share by Application (2013-2018)

11.2 Pre-Exposure Prophylaxis Sales Growth (2013-2018)

11.3 Post-Exposure Prophylaxis Sales Growth (2013-2018)

12 Human Rabies Vaccines Market Forecast (2018-2023)

12.1 Global Human Rabies Vaccines Sales, Revenue and Growth Rate (2018-2023)

12.2 Human Rabies Vaccines Market Forecast by Regions (2018-2023)

12.2.1 North America Human Rabies Vaccines Market Forecast (2018-2023)

12.2.2 Europe Human Rabies Vaccines Market Forecast (2018-2023)

12.2.3 Asia-Pacific Human Rabies Vaccines Market Forecast (2018-2023)

12.2.4 South America Human Rabies Vaccines Market Forecast (2018-2023)

12.2.5 Middle East and Africa Human Rabies Vaccines Market Forecast (2018-2023)

12.3 Human Rabies Vaccines Market Forecast by Type (2018-2023)

12.3.1 Global Human Rabies Vaccines Sales Forecast by Type (2018-2023)

12.3.2 Global Human Rabies Vaccines Market Share Forecast by Type (2018-2023)

12.4 Human Rabies Vaccines Market Forecast by Application (2018-2023)

12.4.1 Global Human Rabies Vaccines Sales Forecast by Application (2018-2023)

12.4.2 Global Human Rabies Vaccines Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Human Rabies Vaccines . Industry analysis & Market Report on Human Rabies Vaccines is a syndicated market report, published as Global Human Rabies Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Human Rabies Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,480.00
$5,220.00
$6,960.00
2,336.82
3,505.23
4,673.64
3,202.30
4,803.44
6,404.59
421,567.20
632,350.80
843,134.40
230,770.63
346,155.95
461,541.26
Add To Cart Credit card Logo

Related Reports


Reason to Buy